This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. (WST) slipped 3.17% to $312.07 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 49,760.56 and the S&amp;P 500 Index falling 0.16% to 7,400.96.
This was the stock's second consecutive day of losses.
West Pharmaceutical Services Inc. closed 5.68% short of its 52-week high of $330.88, which the company reached on May 11th.
The stock underperformed when compared to some of its competitors Tuesday, as Abbott Laboratories (ABT) rose 2.17% to $84.35, Becton Dickinson &amp; Co. (BDX) rose 3.05% to $147.51, and Baxter International Inc. (BAX) rose 2.05% to $17.89.
Trading volume (1.1 M) eclipsed its 50-day average volume of 928,474.
Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-12-26 1704ET

SBIO

LABU

West Pharmaceutical Services Inc. (WST) shares fell 3.17% to $312.07 on Tuesday, marking the second consecutive day of losses. The stock underperformed compared to competitors like Abbott Laboratories, Becton Dickinson, and Baxter International, which saw gains. WST is currently 5.68% below its 52-week high of $330.88 reached on May 11. The trading volume was 1.1 million, surpassing its 50-day average of 928,474.

MarketWatch Automated

West Pharmaceutical

SPDR S&P Biotech

ALPS Medical Breakthrough

VanEck Biotech ETF

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

Direxion S&P Biotech Bull 3X

Proshares Ultra Nasdaq Biotech

Dow Jones Industrial Average

S&P 500

Abbott Laboratories

Becton Dickinson and

Baxter

West Pharmaceutical Services Inc. Stock Underperforms Tuesday When Compared To Competitors